Table 2.
Characteristics of GANFH Patients and Controls
| GANFH group (n=105) | GC-resistant group (n=217) | Healthy control group (n=340) | p | |
|---|---|---|---|---|
| Age, years range (mean±SD) | 18–48 (36.3±9.1) | 20–48 (38.9±8.4) | 18–48 (35.0±10.4) | 0.298a |
| Gender: female, no. (%) | 44 (41.9) | 112 (51.6) | 167 (49.1) | 0.259b |
| Body mass index (mean±SD) | 22.5±3.1 | 23.8±3.0 | 23.7±3.6 | 0.247a |
| Type of underlying disease | ||||
| Organ transplantation, no. (%) | 27 (25.7) | 72 (33.2) | ND | 0.174c |
| Systemic lupus erythematosus, no. (%) | 33 (31.4) | 50 (23.0) | ND | 0.107c |
| Acute lymphoblastic leukemia, no. (%) | 18 (17.1) | 52 (24.0) | ND | 0.164c |
| Others, no. (%) | 27 (25.8) | 43 (19.8) | ND | 0.229c |
a
p-Value among three groups, for ANOVA test.
b
p-Value among three groups, for χ2-test.
c
p-Value between GANFH group and glucocorticoid-resistant group, for χ2-test.
GANFH, glucocorticoid-induced avascular necrosis of the femoral head; GC, glucocorticoid; ND, not determined; χ,2 chi-square.